Bank of Montreal’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.1K | Sell |
12,522
-1,702
| -12% | -$4.49K | ﹤0.01% | 2914 |
|
|
2025
Q1 | $42.8K | Buy |
14,224
+1,502
| +12% | +$4.52K | ﹤0.01% | 2816 |
|
|
2024
Q4 | $32.6K | Sell |
12,722
-249,200
| -95% | -$638K | ﹤0.01% | 2874 |
|
|
2024
Q3 | $1.03M | Buy |
261,922
+250,900
| +2,276% | +$986K | ﹤0.01% | 1781 |
|
|
2024
Q2 | $80.2K | Sell |
11,022
-14,400
| -57% | -$105K | ﹤0.01% | 3013 |
|
|
2024
Q1 | $140K | Sell |
25,422
-36,999
| -59% | -$203K | ﹤0.01% | 2886 |
|
|
2023
Q4 | $325K | Buy |
62,421
+14,061
| +29% | +$73.3K | ﹤0.01% | 2414 |
|
|
2023
Q3 | $87K | Buy |
+48,360
| New | +$87K | ﹤0.01% | 2888 |
|
|
2023
Q2 | – | Sell |
-101,469
| Closed | -$196K | – | 3661 |
|
|
2023
Q1 | $196K | Buy |
101,469
+3,508
| +4% | +$6.77K | ﹤0.01% | 2764 |
|
|
2022
Q4 | $503K | Buy |
97,961
+201
| +0.2% | +$1.03K | ﹤0.01% | 2228 |
|
|
2022
Q3 | $517 | Buy |
+97,760
| New | +$517 | ﹤0.01% | 2188 |
|
|
2021
Q2 | – | Sell |
-32,648
| Closed | -$610K | – | 3974 |
|
|
2021
Q1 | $610K | Buy |
32,648
+24,494
| +300% | +$458K | ﹤0.01% | 2193 |
|
|
2020
Q4 | $117K | Buy |
8,154
+3,392
| +71% | +$48.7K | ﹤0.01% | 3048 |
|
|
2020
Q3 | $36K | Buy |
4,762
+2,473
| +108% | +$18.7K | ﹤0.01% | 3166 |
|
|
2020
Q2 | $32K | Buy |
+2,289
| New | +$32K | ﹤0.01% | 3266 |
|
|
2020
Q1 | – | Sell |
-30,300
| Closed | -$115K | – | 3921 |
|
|
2019
Q4 | $115K | Hold |
30,300
| – | – | ﹤0.01% | 2924 |
|
|
2019
Q3 | $37K | Buy |
+30,300
| New | +$37K | ﹤0.01% | 3285 |
|
|
2019
Q1 | – | Sell |
-379
| Closed | – | – | 4026 |
|
|
2018
Q4 | $0 | Sell |
379
-4
| -1% | – | ﹤0.01% | 4328 |
|
|
2018
Q3 | $2K | Sell |
383
-2
| -0.5% | -$10 | ﹤0.01% | 4028 |
|
|
2018
Q2 | $2K | Buy |
+385
| New | +$2K | ﹤0.01% | 4020 |
|
|
2017
Q4 | – | Sell |
-3,500
| Closed | -$19K | – | 3866 |
|
|
2017
Q3 | $19K | Sell |
3,500
-26,291
| -88% | -$143K | ﹤0.01% | 3252 |
|
|
2017
Q2 | $226K | Buy |
+29,791
| New | +$226K | ﹤0.01% | 2368 |
|